Melanoma in situ of breast (skin) (soft tissue)
ICD-10 D03.52 is a billable code used to indicate a diagnosis of melanoma in situ of breast (skin) (soft tissue).
Melanoma in situ of the breast refers to a localized form of melanoma that has not invaded deeper tissues or metastasized. This condition is characterized by the presence of atypical melanocytes confined to the epidermis, which can be detected through skin examinations and biopsies. Melanoma in situ is often asymptomatic and may present as a pigmented lesion or a change in an existing mole. Early detection is crucial, as the risk of progression to invasive melanoma increases if left untreated. Surveillance protocols typically involve regular dermatological examinations, patient education on self-examination techniques, and monitoring for changes in skin lesions. The prognosis for melanoma in situ is generally favorable, with a high cure rate when treated appropriately. However, patients with a history of melanoma in situ require ongoing surveillance due to the potential for recurrence or development of new primary melanomas.
Detailed descriptions of lesions, biopsy results, and follow-up plans.
Skin examinations, biopsy of suspicious lesions, and management of melanoma in situ.
Ensure clear documentation of lesion characteristics and patient history to support coding.
Comprehensive treatment plans, staging information, and follow-up care documentation.
Management of melanoma patients, including surgical interventions and surveillance protocols.
Accurate coding of treatment modalities and monitoring for recurrence is essential.
Used when excising melanoma in situ from the breast.
Operative notes detailing the size and location of the lesion.
Dermatology and oncology must coordinate on excision and follow-up care.
Melanoma in situ is confined to the epidermis and has not invaded deeper tissues, while invasive melanoma has penetrated beyond the epidermis into the dermis or deeper layers.
